SIREN : 501773881
LUXLAB is a French company founded 18 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in CRETEIL (94000), this company of category PME shows in 2022 a revenue of 172 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | 171 755 € | 199 386 € | 169 668 € | 192 246 € | 176 424 € |
| Net income | 0 € | 0 € | 15 502 € | 6 560 € | 360 € | -8 688 € | 5 665 € |
| EBITDA | N/C | N/C | 18 272 € | 11 669 € | 3 904 € | -4 300 € | 15 363 € |
| Net margin | N/C | N/C | 9.0% | 3.3% | 0.2% | -4.5% | 3.2% |
In 2024, LUXLAB records a net loss of 0 €. This deficit will reduce equity on the balance sheet. Change over 2016-2022: 6 k€ -> 0 €.
The debt ratio (= Financial debt / Equity x 100) stands at 83%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.
82.812%
36.125%
57.1%
In 2024, the debt ratio of LUXLAB (82.81) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of LUXLAB (36.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2022, the repayment capacity of LUXLAB (0.82) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 179.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
179.719
In 2024, the liquidity ratio of LUXLAB (179.72) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2022, the interest coverage of LUXLAB (10.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Compare LUXLAB with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of LUXLAB in 2022 is 172 k€.
Yes, LUXLAB generated a net profit of 16 k€ in 2022.
The headquarters of LUXLAB is located in CRETEIL (94000), in the department Val-de-Marne.
The tax return of LUXLAB is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LUXLAB operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.